AR010643A1 - Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento. - Google Patents

Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento.

Info

Publication number
AR010643A1
AR010643A1 ARP970105524A ARP970105524A AR010643A1 AR 010643 A1 AR010643 A1 AR 010643A1 AR P970105524 A ARP970105524 A AR P970105524A AR P970105524 A ARP970105524 A AR P970105524A AR 010643 A1 AR010643 A1 AR 010643A1
Authority
AR
Argentina
Prior art keywords
hydrogen
compounds
compound
unsubstituted
manufacture
Prior art date
Application number
ARP970105524A
Other languages
English (en)
Spanish (es)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR010643A1 publication Critical patent/AR010643A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
ARP970105524A 1996-11-25 1997-11-25 Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento. AR010643A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
AR010643A1 true AR010643A1 (es) 2000-06-28

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105524A AR010643A1 (es) 1996-11-25 1997-11-25 Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento.

Country Status (20)

Country Link
EP (1) EP0944620A1 (xx)
JP (1) JP2001506599A (xx)
KR (1) KR20000069104A (xx)
CN (1) CN1244864A (xx)
AR (1) AR010643A1 (xx)
AU (1) AU5433998A (xx)
BR (1) BR9713535A (xx)
CA (1) CA2272644A1 (xx)
CO (1) CO4910166A1 (xx)
CZ (1) CZ183999A3 (xx)
HU (1) HUP9904660A3 (xx)
ID (1) ID22676A (xx)
IL (1) IL130067A0 (xx)
NO (1) NO992502L (xx)
NZ (1) NZ335882A (xx)
PE (1) PE47099A1 (xx)
SK (1) SK69699A3 (xx)
TR (1) TR199901542T2 (xx)
WO (1) WO1998023609A1 (xx)
ZA (1) ZA9710576B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
EP2226315A4 (en) 2007-12-28 2012-01-25 Carna Biosciences Inc 2-AMINOQUINAZOLINE DERIVATIVE
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
CA2179006A1 (en) * 1993-12-17 1995-06-22 Peter Julian Maurer 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists

Also Published As

Publication number Publication date
NZ335882A (en) 2000-12-22
EP0944620A1 (en) 1999-09-29
WO1998023609A1 (en) 1998-06-04
PE47099A1 (es) 1999-06-12
JP2001506599A (ja) 2001-05-22
TR199901542T2 (xx) 2000-01-21
IL130067A0 (en) 2000-02-29
CN1244864A (zh) 2000-02-16
HUP9904660A2 (hu) 2000-06-28
SK69699A3 (en) 2000-06-12
BR9713535A (pt) 2000-03-21
CZ183999A3 (cs) 1999-11-17
CO4910166A1 (es) 2000-04-24
NO992502D0 (no) 1999-05-25
NO992502L (no) 1999-07-26
KR20000069104A (ko) 2000-11-25
AU5433998A (en) 1998-06-22
HUP9904660A3 (en) 2002-02-28
ID22676A (id) 1999-12-09
CA2272644A1 (en) 1998-06-04
ZA9710576B (en) 1998-09-16

Similar Documents

Publication Publication Date Title
AR013875A1 (es) Compuesto 2-imidazolinilaminoindol, composicion farmaceutica que comprende dicho compuesto y uso del mismo para la fabricacion de un medicamento.
CO4810373A1 (es) Compuestos azapoliciclicos condensados con arilo
ES2163071T3 (es) Sulfonamidas y su utilizacion.
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
YU54896A (sh) (methilsulfonil)fenil-2-(5h)-furanoni kao cox-2 inhibitori
BR0312999A (pt) Compostos, composições farmacêticas, método para aumentar a cognição, de tratamento, de inibição da atividade de enzima pde4 em um paciente
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
AR033594A1 (es) Un compuesto derivado de 3-aroilindol, su utilizacion, procedimientos para prepararlo, una composicion farmaceutica que lo contiene, un medicamento constituido por dicho compuesto, y compuestos intermediarios
AR009145A1 (es) Compuetos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores y composiciones farmaceuticas que los comprenden
UY25780A1 (es) Nuevos antibióticos macrólidos
AR022019A1 (es) Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen
PA8471301A1 (es) Compuestos azapoliciclicos condensados con arilo
CO4910150A1 (es) Compuestos de 2-imidazolinilaminobenzoxazol utiles con agonistas de alfa-2 adrenoceptores
AR010643A1 (es) Compuestos de 2-imidazolinilaminoindazol, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento.
AR029461A1 (es) Derivados de 4-fenil-1-piperazinilo, - piperidinilo y -tetrahidropiridilo , composiciones farmaceuticas que los comprenden y el uso de los mismos para la fabricacion de un medicamento
BR9911250A (pt) Processo para preparação de compostos
AR017146A1 (es) Compuestos de 1-(fenil-sustituido)-5-(4-metilsulfonilfenil)pirazol; procedimiento para prepararlos, las composiciones farmaceuticas que los contienen,los agentes inhibidores de la cox-ii que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos.
PT1234818E (pt) Sais de calcio de derivados de 1,5-benzodiazepina, processo para producao dos sais e drogas que os contem
UY26147A1 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
BR0313000A (pt) Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
AR009144A1 (es) Compuestos heterociclicos guanidilamino, composicion farmaceutica que comprende dicho compuesto y uso del mismo para la fabricacion de un medicamento
PE16199A1 (es) Compuestos de 2-imidazolinilaminobenzotiazol utiles como agonistas de alfa-2 adrenoreceptores
BRPI0204489B8 (pt) "derivado de rodamina, composição farmacêutica, intermediário, e, processo para a síntese de novos derivados rodamina".